Latest News about Market/Moving Exclusives
Recent news which mentions Market/Moving Exclusives
EXCLUSIVE: Ligand Subsidiary Pelthos Therapeutics To Combine with Channel Therapeutics Creating Pain Medicines Focused Entity
Today 5:45 EDT
From Benzinga
EXCLUSIVE: La Rosa FY24 Revenue Jumps 119%, CEO Reiterates FY25 Topline Goal Of $100 Million
April 16, 2025
From Benzinga
EXCLUSIVE: MIRA Pharmaceuticals Ketamir-2 Shows Efficacy In Diabetes-Associated Nerve Damage In Animal Study
April 16, 2025
From Benzinga
EXCLUSIVE: Vivani Medical Collaborates With Okava To Expand Development Of GLP-1 Therapy For Dogs
April 15, 2025
From Benzinga
From Benzinga
EXCLUSIVE: Janover Acquires $4.6 Million Of Solana (SOL), Begins Digital Asset Treasury Strategy
April 10, 2025
From Benzinga
EXCLUSIVE: Capstone Eyes $100 Million Goal With Southeast Expansion, Targets 1,500 Acquisition Opportunities
April 09, 2025
From Benzinga
EXCLUSIVE: Anixa Biosciences Receives Key US Patent Nod For Breast Cancer Vaccine Patent
April 09, 2025
From Benzinga
From Benzinga
EXCLUSIVE: Capstone Clocks 8% Q4 Revenue Growth, Aims For $100 Million Revenue Run Rate By 2025
April 01, 2025
From Benzinga
From Benzinga
EXCLUSIVE: Intelligent Bio Solutions Adds Sixth US Patent For Its Drug Screening Technology
March 26, 2025
From Benzinga
EXCLUSIVE: Vivani Medical Subdermal Semaglutide Implant Shows 20% Weight Loss In Animal Study, With Potential For Once-Yearly Dosing
March 26, 2025
From Benzinga
From Benzinga
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
